³ÉÈËVRÊÓƵ

Yasser Riazalhosseini, PhD, Associate Professor in the Department of Human Genetics, and Head of Cancer Genomics at the  and clinicians from ³ÉÈËVRÊÓƵ Health Centre have received funding from the US Department of Defense (DoD) for nearly $2M to discover improved methods for risk assessment and therapeutic treatment to fight against clear cell renal cell carcinoma (ccRCC), the most common subtype of kidney cancer. .